Literature DB >> 668780

Haemodynamic effects of molsidomin.

K R Karsch, K P Rentrop, H Blanke, H Kreuzer.   

Abstract

Hemodynamic changes for 30 min after intravenous administration of molsidomin 4 mg were studied in 10 patients. Pulmonary artery pressure, pulmonary wedge pressure, right atrial pressure and aortic pressure decreased significantly after 15 min, and after 30 min they were still below the control level. Heart rate increased significantly (by 15%) 15 min after injection, and after 30 min it was still 8% above the control value. Cardiac index decreased significantly from 3.37 +/- 0.12 to 2.95 +/- 0.15 1/min/m2. Peripheral and pulmonary resistance showed no significant change. Both stroke work index and minute work decreased significantly 15 min after administration of molsidomin and after 30 min both were still below the control level. The results suggest that molsidomin decreases preload without influencing afterload. By decreasing preload, molsidomin improves the oxygen supply/demand ratio of the myocardium.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 668780     DOI: 10.1007/BF00716357

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  9 in total

1.  Coronary collateral vasodilator action of N-ethoxycarbonyl-3-morpholinosydnonimine (SIN-10) in heart with chronic coronary insufficiency in dogs.

Authors:  M Hirata; K Kikuchi
Journal:  Jpn J Pharmacol       Date:  1970-06

2.  Measurement of aortic compliance in vivo.

Authors:  J Iriuchijima; A Kumazawa; K Kawakami
Journal:  Jpn Heart J       Date:  1971-09

3.  Hypotensive action of N-ethoxycarbonyl3-morpholinosydnonimine, SIN-10.

Authors:  K Kikuchi; M Hirata; A Nagaoka
Journal:  Jpn J Pharmacol       Date:  1970-03

4.  [Effect of Molsidomin on the hemodynamics and working tolerance of patients with angina pectoris].

Authors:  J Slany; H Mösslacher; R Schmoliner; G Krinik
Journal:  Med Welt       Date:  1976-12-03

5.  The mode of hypotensive action of newly synthesized sydnonimine derivatives.

Authors:  K Hashimoto; N Taira; M Hirata
Journal:  Arzneimittelforschung       Date:  1971-09

6.  Effects of nitrites on arterial collateral vessels of dogs.

Authors:  J Iriuchijima
Journal:  Jpn Heart J       Date:  1971-11

7.  Effects of N-ethoxycarbonyl-3-morpholinosyndnonimine (SIN-10) on the cardiovascular system.

Authors:  F Takenaka; N Takeya; T Ishihara; S Inoue; E Tsutsumi
Journal:  Jpn J Pharmacol       Date:  1970-06

8.  [Studies on the influence of Molsidomin on coronary heart disease (author's transl)].

Authors:  E Jansen; H Klepzig
Journal:  Med Klin       Date:  1976-11-19

9.  [An improved exercise test in coronary-heart disease: effect of molsidomin on erogometrically controlled exercise (author's transl)].

Authors:  G Blazek; H Heeger; F Kubicek
Journal:  Dtsch Med Wochenschr       Date:  1977-01-21       Impact factor: 0.628

  9 in total
  8 in total

1.  Intravenous and oral administration of molsidomine, a pharmacodynamic and pharmacokinetic study.

Authors:  R Bergstrand; A Vedin; C Wilhelmsson; L E Peterson; J Chamberlain; D Dell; L A Stevens; J Ostrowski
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

2.  Increased effective vascular compliance and venous pooling of intravascular volume during sustained venodilation in conscious dogs.

Authors:  J Holtz; E Bassenge; H Kinadeter; A Kolin
Journal:  Basic Res Cardiol       Date:  1981 Nov-Dec       Impact factor: 17.165

3.  Effects of molsidomine, nitroglycerin, and isosorbide dinitrate on the coronary circulation, myocardial oxygen consumption, and haemodynamics in anaesthetized dogs.

Authors:  V B Fiedler; R E Nitz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-08       Impact factor: 3.000

4.  Haemodynamic effects of oral molsidomine in pump failure complicating myocardial infarction.

Authors:  S Drajer; H Cercós; H Torres; A Vazquez; J L Cohn; N Romero; G Faerman; S Soifer; C M Nijensohn
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

5.  Pharmacokinetics of molsidomine and its active metabolite, linsidomine, in patients with liver cirrhosis.

Authors:  O Spreux-Varoquaux; J Doll; C Dutot; N Grandjean; P Cordonnier; M Pays; J Andrieu; C Advenier
Journal:  Br J Clin Pharmacol       Date:  1991-09       Impact factor: 4.335

6.  Comparative study of the haemodynamic effects of oral molsidomine and isosorbide dinitrate in man.

Authors:  A Vogt; H Kreuzer
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

7.  Effects of molsidomine on the coronary circulation in anesthetized dogs.

Authors:  V B Fiedler; R E Nitz
Journal:  Basic Res Cardiol       Date:  1982 May-Jun       Impact factor: 17.165

8.  [Effect of molsidomine on hemodynamics and myocardial ischemia in patients with acute myocardial infarction (author's transl)].

Authors:  W D Bussmann; K Neidl; M Kaltenbach
Journal:  Klin Wochenschr       Date:  1982-01-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.